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Mapping the O-Mannose Glycoproteome in
Saccharomyces cerevisiae*□S
Patrick Neubert‡**, Adnan Halim§**, Martin Zauser‡, Andreas Essig¶, Hiren J. Joshi§,
Ewa Zatorska‡, Ida Signe Bohse Larsen§, Martin Loibl‡, Joan Castells-Ballester‡,
Markus Aebi¶, Henrik Clausen§, and Sabine Strahl‡
O-Mannosylation is a vital protein modification conserved
from fungi to humans. Yeast is a perfect model to study
this post-translational modification, because in contrast
to mammals O-mannosylation is the only type of O-glyco-
sylation. In an essential step toward the full understanding
of protein O-mannosylation we mapped the O-mannose
glycoproteome in baker’s yeast. Taking advantage of an
O-glycan elongation deficient yeast strain to simplify sam-
ple complexity, we identified over 500 O-glycoproteins
from all subcellular compartments for which over 2300
O-mannosylation sites were mapped by electron-transfer
dissociation (ETD)-based MS/MS. In this study, we focus
on the 293 O-glycoproteins (over 1900 glycosylation sites
identified by ETD-MS/MS) that enter the secretory path-
way and are targets of ER-localized protein O-mannosyl-
transferases. We find that O-mannosylation is not only a
prominent modification of cell wall and plasma membrane
proteins, but also of a large number of proteins from the
secretory pathway with crucial functions in protein glyco-
sylation, folding, quality control, and trafficking. The anal-
ysis of glycosylation sites revealed that O-mannosylation
is favored in unstructured regions and -strands. Further-
more, O-mannosylation is impeded in the proximity of
N-glycosylation sites suggesting the interplay of these
types of post-translational modifications. The detailed
knowledge of the target proteins and their O-mannosyla-
tion sites opens for discovery of new roles of this essen-
tial modification in eukaryotes, and for a first glance on
the evolution of different types of O-glycosylation from
yeast to mammals. Molecular & Cellular Proteomics 15:
10.1074/mcp.M115.057505, 1323–1337, 2016.
Protein glycosylation is one of the most diverse, complex,
and energetically costly post-translational modifications. The
most common types are N- and O-glycosylation with glycans
attached to the amide group of Asn residues of the sequon
Asn-X-Ser/Thr, and to the hydroxy amino acids Ser and Thr,
respectively. Although various types of O-glycosylation have
evolved in mammals (i.e. O-linked N-acetylgalactosamine (O-
GalNAc), N-acetylglucosamine, xylose, fucose, or glucose),
only O-mannosylation is conserved between fungi, animals,
and humans (1). In higher eukaryotes, O-mannosylation is
essential for growth and development, and failures result in
severe congenital human disorders, stressing its importance
(2–5). In baker’s yeast, O-mannosylation is equally essential
and it is the only identified type of protein O-glycosylation
making Saccharomyces cerevisiae an ideal model to study
this post-translational modification. However, still very little is
known about theO-mannose (O-Man)1 glycoproteome as well
as the biological functions of O-mannosyl (O-Man) glycans.
In eukaryotes, biosynthesis of O-Man glycans on proteins
trafficking the secretory pathway is initiated at the luminal side
of the endoplasmic reticulum (ER) membrane by the con-
served family of protein O-mannosyltransferases (PMTs, in
mammals called POMTs) that catalyze the transfer of man-
nose from dolichol-phosphate -D-mannose, an activated
lipid-linked mannosyl donor, to the substrate glycoproteins (6,
7). This reaction takes place at the ER translocon on co- and
post-translationally translocating nascent polypeptides, as we
recently showed in baker’s yeast (8). While traveling through
the secretory pathway from the ER to later destinations, the
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protein-linked mannose residues can be further extended by
the addition of different sugar residues, giving rise to more
complex glycan structures that vary between species. In bak-
er’s yeast, O-Man glycan elongation is mediated by the 1,2-
mannosyltransferases of the KTR family (i.e. Kre2, Ktr1, Ktr3)
and the 1,3-mannosyltansferases from the MNN1 family in
the Golgi apparatus (9). As a result linear oligo-mannose
structures of heterogenous length arise (10).
To our best knowledge O-mannosylation of less than 40
yeast proteins, mainly including extracellular, cell wall-local-
ized, and plasma membrane proteins have been shown so far
(reviewed in (11)). In addition, only about 90 O-Man glycosites
have been experimentally assigned, all in only seven cell wall
proteins (Aga1, Ccw5, Ccw12–14, Sag1, Sed1; (12–16)). Most
of these O-Man glycans are situated in Ser/Thr-rich protein
regions. Although around 18% of signal peptide-containing
proteins have been predicted by computational analyses to
contain at least one Ser/Thr-rich region, exact motifs that
determine PMT-based O-mannosylation have only been ex-
plored in part (6, 17–19).
Proteome-wide analysis of O-glycosylation has long been
limited by technical constraints but recent advances in en-
richment strategies of glycopeptides followed by MS se-
quencing have paved the way for O-glycoproteomics studies
(20). We recently characterized the human O-Man glycopro-
teome taking advantage of the so-called “SimpleCell” strat-
egy that resulted in the identification of cadherins as major
targets ofO-mannosylation in mammals (21). Key to this study
was the use of a genetically engineered cell line where early
glycan elongation steps in the Golgi apparatus are omitted to
simplify and hence effectively reduce the sample complexity.
The “SimpleCell” strategy enabled sensitive isolation and se-
quencing of O-glycopeptides using a combination of lectin
weak affinity chromatography (LWAC) and higher-energy col-
lision-induced dissociation-electron-transfer dissociation (HCD/
ETD)-based MS/MS (20, 21).
Here, we took advantage of a yeast mutant in which O-
linked mannose residues are barely extended in the Golgi
apparatus to determine the first comprehensive O-Man gly-
coproteome in Saccharomyces cerevisiae. We analyzed total
cell lysates using the shotgun LWAC enrichment strategy
developed for the human O-Man glycoproteome to obtain a
global view. In addition, we applied a targeted approach to
probe cell wall proteins specifically, which validated the sen-
sitivity and robustness of the shotgun strategy. This way, we
identified 511 O-Man glycoproteins from all major cellular
compartments including a subset of nucleocytoplasmic pro-
teins that is discussed in a separate study (22). Here, we focus
on 293 proteins that enter the secretory pathway and thus are
glycosylated by the ER-located PMTs. For these proteins, we
identified over 1900 O-Man sites by ETD-MS/MS and over
260 additional O-Man sites by HCD-MS/MS. The large data-
set identified numerous previously unknown targets and re-
vealed hallmarks of PMT-based protein O-mannosylation.
Our study gives insight into conserved features of O-glycosy-
lation between yeast and mammals.
EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids—S. cerevisiae strains and plasmids
used in this study are summarized in supplemental Table S1 and
Supplemental Experimental Procedures. Yeast cells were grown in
YPD (1% yeast extract, 2% peptone, 2% glucose) under standard
conditions.
Preparation of Shotgun LWAC-enriched O-Man Glycopeptides
from Total Cell Lysates—Total cell lysates were prepared from a total
of 100 OD600 units of mid-log phase yeast cells (strains BY4741 and
KTR) with 0.25–0.5 mm glass beads in 400 l of ice-cold 0.1% (w/v)
Rapigest (Waters Corp., Milford, MA) in 50 mM NH4HCO3 using a
Hybaid RiboLyser (Thermo Fisher Scientific, Bonn, Germany; 4 25 s
with 1 min intervals at 4 °C). After cell lysis, the bottom of the tube was
punctured, and the lysate was collected. Cell debris was removed by
centrifugation at 1500  g for 5 min at 4 °C. Cleared lysates were
heated at 80 °C for 10 min, followed by reduction in 5 mM DTT at
60 °C for 30 min and alkylation in 10 mM iodoacetamide at room
temperature for 30 min. Samples were digested with either 25 g
trypsin (Roche Diagnostics, Mannheim, Germany), 20 g GluC
(Staphylococcus aureus Protease V8), or 25 g chymotrypsin (Pro-
mega, Madison, WI) over night. After incubation at 95 °C for 20 min,
samples were treated with 8 U Peptide-N-Glycosidase F (PNGase F;
Roche Diagnostics) over night at 37 °C. An additional 4 U PNGase F
was added and samples incubated for additional 4h at 37 °C. The
digests were acidified with 12 l TFA, incubated at 37 °C for 20 min,
cleared by centrifugation at 10,000  g for 10 min, and purified by
Sep-Pak C18 (Waters, Dublin, Ireland) columns. Purified peptides
were dried by evaporation, and then solved in 2 Con A buffer A (21).
O-Man glycopeptides were enriched by LWAC and further fraction-
ated by isoelectric focusing (IEF) as previously described (21, 23). MS
analysis was performed on Con A-enriched glycopeptide fractions
prepared from wild-type (WT) and KTR cells. In total, data were
collected from eight independent preparations. Total cell lysates from
KTR were digested by trypsin in triplicates, and digested by GluC
and chymotrypsin in duplicates each. Additionally, data were col-
lected from a single WT cell extract digested by trypsin.
Preparation of (Glyco-)Peptides from Enriched Covalently Linked
Cell Wall Proteins—The protocol was adapted from Schulz and Aebi
(24) and optimized for ETD-MS/MS measurements of O-mannosy-
lated cell wall proteins. Briefly, 50 OD600 units of cells (strain SS328)
were used to prepare total cell lysates. Cell walls were collected and
resuspended in denaturing buffer (50 mM Tris-HCl, pH 7.5, 2 M thio-
urea, 7 M urea, 2% (w/v) SDS). Cell wall proteins were reduced by
DTT, and after alkylation the cell wall pellet was extensively washed
with denaturing buffer and subsequently with 2% (w/v) SDS. The
pellet was then dissolved in 2% SDS and the N-glycans trimmed
down to a single HexNAc by the endoglycosidase H (Endo H) for 16 h
according to the manufacturer’s protocol (New England Biolabs,
Frankfurt/Main, Germany). After washing and dissolving the pellet in
50 mM Na4HCO3 (pH 8), the cell wall proteins were digested with
either AspN (2 g/ml; Merck Millipore, Darmstadt, Germany), LysC
(20 g/ml; Wako, Osaka, Japan), or LysN (6 g/ml; U-Protein Express
BV, Utrecht, Netherlands) at 37 °C for 16 h. The released peptides
were separated from the remaining cell wall material by centrifugation
at 16,000  g for 1 min, and completely dried in a centrifugal evap-
orator. The peptides were dissolved in 100 mM sodium acetate buffer
(pH 4.6) and treated with -mannosidase from Jack bean at 37 °C for
16 h. Afterward, the peptide solution was acidified with formic acid to
pH 2–3 and desalted using C18 ZipTip pipette tips (Merck Millipore).
For the LysN digest, HCD-MS/MS was performed with the same
extract as prepared for ETD. For the LysC digest, the ETD and HCD
The O-Mannose Glycoproteome in Baker’s Yeast
1324 Molecular & Cellular Proteomics 15.4
measurements were performed with two independently prepared ex-
tracts. ETD was solely used for the extract digested with AspN.
nLC-MS/MS—MS analyses of IEF fractions of O-Man glycopep-
tides enriched from total cell lysates by Con A LWAC were performed
essentially as previously described (21). Briefly, samples were ana-
lyzed on a set up composed of an EASY-nLC 1000 (Thermo Fisher
Scientific, Bremen, Germany) interfaced via a nanoSpray Flex ion
source to an LTQ-Orbitrap Velos Pro hybrid spectrometer (Thermo
Fisher Scientific) or Fusion Tribrid mass spectrometer (Thermo Fisher
Scientific). The EASY-nLC 1000 was operated using a single analyt-
ical column setup (PicoFrit Emitters, 75 m inner diameter; New
Objectives, Woburn, MA) packed in-house with Reprosil-Pure-AQ
C18 phase (1.9 m particle size; Dr. Maisch, Ammersbach, Germany).
Peptides were separated using a 120 min LC gradient operated at 200
nL/min. The mobile phases were composed of solvent A (H2O) and
solvent B (acetonitrile); both solvents containing 0.1% formic acid
(v/v). The gradient was 2–25% B for 95 min followed by 25–80% B for
10 min and finally 80% B for 15 min. For Velos Pro acquisition,
precursor MS1 scan (m/z 350–1700) was acquired in the Orbitrap at
a resolution setting of 30,000, followed by Orbitrap HCD-MS/MS and
ETD-MS/MS of the five most abundant multiply charged precursors in
the MS1 spectrum; a minimum MS1 signal threshold of 50,000 ions
was used for triggering data-dependent fragmentation events; MS2
spectra were acquired at a resolution of 15,000. For Fusion acquisi-
tion, precursor MS1 scan (m/z 355–1700) was acquired in the Orbitrap
at a resolution setting of 120,000, followed by Orbitrap HCD-MS/MS
and ETD-MS/MS of the five most abundant multiply charged precur-
sors in the MS1 spectrum; a minimum MS1 signal threshold of 10,000
ions was used for triggering data-dependent fragmentation events;
MS2 spectra were acquired at a resolution of 30,000. Data processing
was carried out using Proteome Discoverer 1.4 software (Thermo
Fisher Scientific) as previously described (21) with minor modifica-
tions as outlined below. Raw data files (.raw) were processed using
the Sequest HT node and searched against the canonical S. cerevi-
siae proteome (7225 entries) downloaded from the UniprotKB (http://
www.uniprot.org/; October, 2013). In all cases, the precursor mass
tolerance was set to 10 ppm and fragment ion mass tolerance to 0.05
Da. Carbamidomethylation on Cys was used as a fixed modification,
oxidation of Met, deamidation of Asn and hexosylation of Ser and Thr
were used as variable modifications. A maximum of eight variable
modifications were allowed per peptide. A maximum of two missed
cleavage sites were tolerated. Spectral assignments at the medium
confidence level (p  0.01) and below were resubmitted to a second
Sequest HT node using semispecific trypsin, chymotrypsin, or GluC
proteolytic cleavage. Final results were filtered for high-confidence
(p  0.01) identifications only. Peptide confidence levels were calcu-
lated using the Target Decoy PSM Validator node of Proteome Dis-
coverer 1.4. HCD spectra were further processed with a subtraction
routine as previously described (23). Briefly, all HCD spectra were
extracted to a separate .mgf file and the exact masses of one to four
hexose residues were subtracted from each precursor ion resulting in
four separate .mgf files. Each .mgf file was subsequently processes
as described above with the exception of omitting hexose as variable
modification at Ser or Thr residues.
MS analyses of (glyco-)peptides from enriched covalently linked
cell wall proteins were performed on a hybrid Velos LTQ Orbitrap
mass spectrometer (Thermo Scientific) equipped with an ETD unit and
coupled to an Eksigent-nano-HPLC system (Eksigent Technologies,
Dublin, CA). Separation of peptides was done on a self-made column
(75 m  80 mm) packed with C18 AQ 3 m resin (Bischoff Chro-
matography, Leonberg, Germany). Peptides were eluted with a linear
gradient from 2–31% acetonitrile in 53 min at a flow rate of 250
nL/min. For ETD measurements, full MS data were acquired in the
Orbitrap unit in a mass range of 300–1700 m/z, with an automatic
gain control (AGC) setting of 1  106, at a resolution of 60,000 at 400
m/z and a maximum injection time of 250 ms. ETD-MS/MS spectra
were acquired in the data dependent mode with up to 10 ETD spectra
recorded in the linear ion trap (50 ms injection time). A minimal signal
threshold of 1000 was required to trigger the MS/MS acquisition.
Supplemental activation energy was activated, and the AGC value
was set at 5  104. Fluoranthene was used as anion with an AGC
value of 1  105 and a reaction time of 100 ms. For HCD measure-
ments, full MS scans were done at a resolution of 30,000 at 400 m/z
(250 ms injection time). A maximum of 10 HCD MS/MS scans were
acquired with normalized collision energy set to 40%, enabling the
collision energy to be stepped (width 15%, three steps). Fragment
ions were detected in the Orbitrap at a resolution of 7500 at 400 m/z
(200 ms injection time). All measurements were performed with one
microscan with the exception of the LysN ETD measurement with two
microscans for the MS/MS acquisition. The Mascot Distiller v2.5
(Matrix Science Inc.) was used to convert MS and MS/MS spectra in
Mascot generic format (mgf). For all measurements, MS/MS spectra
were searched against the S. cerevisiae in-house protein database
including common contaminants (fgcz_4932; sequences based on
the Uniprot S. cerevisiae reference proteome 559292) using the Mas-
cot search algorithm v2.4 (Matrix Science Inc.) with the following
parameters: Carbamidomethylation (Cys) as fixed modification; oxi-
dation (Met), hexose (Ser), hexose (Thr) as variable modifications for
ETD measurements and neutral loss of hexose for HCD measure-
ments in addition to oxidation of methionine. Further, a peptide tol-
erance of 5 ppm and a fragment ion tolerance of 0.8 Da or 0.02 Da
were used for ETD or HCD, respectively. LysC, LysN, or AspN were
set as proteases with a maximum of three missed cleavages. The
maximum false discovery rate was set at 1% and peptides with an
e-value of above 0.05 were rejected. All acquired data were manually
verified using the Mascot search output and the Xcalibur software
v2.0 (Thermo Scientific).
Data Analysis and Bioinformatics—Gene Ontology (GO) term anal-
ysis was performed using the Database for Annotation, Visualization,
and Integrated Discovery (DAVID, v6.7; (25)). Subcellular localization
was additionally analyzed based on manually curated information
from the Saccharomyces Genome Database (SGD; (26)) and high-
confidence cellular component GO terms extracted from the Com-
partments database ((27); April, 2015). GO terms of interest were
filtered manually: wherever possible child terms that refer to extrinsic
parts of membranes were excluded from membrane-enclosed com-
partments, and integral or intrinsic parts of membrane parts were
counted toward the membrane-enclosed compartments. Proteins
that did not match the criteria and could not be assigned to a specific
subcellular localization were regarded as not annotated (NA).
Sequence analysis was performed using an in-house prepared “R”
script, which is available upon request. For sliding window analysis a
default window size of 21 amino acids were chosen. This way, the
Ser/Thr-content, the hydropathy (according to Kyle & Doolittle, (28)),
the FoldIndex(c) (http://bip.weizmann.ac.il/fldbin/findex, (29)) were
calculated for every O-Man site of the secretome. Secondary struc-
ture probabilities were predicted externally using NetSurfP 1.1 (http://
www.cbs.dtu.dk/services/NetSurfP/, (30)). The corresponding se-
quence windows were used for single-sided (WebLogo 3.4, http://
weblogo.threeplusone.com) and two-sided Logo-plots (www.two
samplelogo.org), respectively (31, 32). Two-sample Logo-plots were
tested against all Ser/Thr positions of the secretome as a reference
with a threshold of p  0.01.
Nonreductive -Elimination and HPEAC-PAD—O-Man glycans
were released from tryptic peptides of total cell lysates by nonreduc-
tive -elimination according to Zheng et al. (33), and separated from
the peptides by solid phase extraction (Sep-Pak C18, Waters). High-
performance anion-exchange liquid chromatography with pulsed am-
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perometric detection (HPEAC-PAD) was performed according to the
literature (34), using a CarboPac PA1 column connected to the ICS-
3000 system (Dionex, Germering, Germany) and quantified by PAD.
The column was equilibrated with five column volumes of solvent A
(ultra-pure H2O) at a flow rate of 1 ml min
1. Column temperature was
kept contant at 25 °C. Baseline separation of carbohydrates was
achieved by increasing the concentration of solvent B (300 mM NaOH)
in solvent A as follows: From 0 to 25 min 7.4% B, followed by a
gradient to 100% B within 12 min, hold for 8 min at 100% B, return to
7.4% B and equilibration of the column for 12 min. Data acquisition
and quantification was performed with Chromeleon 6.7 (Dionex).
Western Blot Analysis of Total Cell Lysates—Total cell lysates were
prepared in ice-cold 1  TBS buffer including 1 mM PMSF and 1
mg/ml pepstatin. Proteins were analyzed by Western blot as previ-
ously described (18). Polyclonal anti-Hsp150 (35) was used at a
dilution of 1:5000, and anti-Kex2 (gift of W. Tanner) at a dilution of
1:1000.
Cell Free Microsomal Translation/Translocation Assay—In vitro pro-
tein translation and translocation into yeast microsomes (strain
SEY6210) was performed as described recently (8). Proteins were
separated on 15% polyacrylamide gels and detected by Western blot
using the anti-FLAG (Sigma-Aldrich, Taufkirchen, Germany) monoclo-
nal antibodies at a dilution of 1:10,000. For Endo H treatment micro-
somes (24 g) were purified, resuspended in denaturing buffer and
heated at 65 °C for 15 min. Thereafter, 250 U of Endo H (New England
Biolabs) were added and samples incubated at 37 °C for 1 h in the
presence of 5 mM PMSF. Experimental details are outlined in the
supplemental Experimental Procedures.
Experimental Design and Statistical Rationale—In total, eight
MS/MS datasets were recorded for enriched O-Man glycoproteins
from WT and KTR cells, each comprising results from data proc-
essing of HCD- and ETD activation types as well as results from
processed spectra accounting neutral loss of one to five hexoses.
Digests of KTR cells were performed in duplicate, so that two
datasets each originated from trypsin, GluC, and chymotrypsin di-
gestion. A single dataset originated from tryptic digests of WT cells
and were included for analysis because the results were found in
strong accordance with the results obtained from KTR cells. Micro-
somal translation/translocation assay, and glycan profiling using
HPEAC-PAD were performed at least in biological triplicates.
RESULTS
LWAC Enrichment of O-Man Glycopeptides Identified 511
Glycoproteins and Over 2600 O-Glycosylation Sites—We
set out to map the O-Man glycoproteome in baker’s yeast
using our recently developed shotgun LWAC enrichment
approach and HCD/ETD-based MS/MS. In addition to WT
yeast, we used a mutant strain lacking the three major Golgi-
located 1,2-mannosyltransferases Kre2, Ktr1, and Ktr3 (9) in
order to reduce the sample complexity of peptides bearing
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glycan chains of heterogeneous length (Fig. 1A). In the
kre2ktr1ktr3 (KTR) mutant the elongation of O-linked
mannoses in the Golgi apparatus is blocked to a large extent
when compared with the WT strain and the single mutants
(Fig. 1B, 1C; (36)). As an example for the simplification of the
O-Man glycans in this mutant, the electrophoretic mobility
shift of the known highly O-mannosylated, secreted heat
shock protein Hsp150, and the moderately O-mannosylated
Golgi-resident protease Kex2 (37) are shown in Fig. 1B. In
addition, the relative quantification of peptide-bound single
mannose residues from tryptic digests (for details see Exper-
imental Procedures) by HPEAC-PAD further showed the sub-
stantial reduction of the heterogeneity of glycan chain length
in this mutant (Fig. 1C).
Total cell lysates from the WT strain and the KTR mutant
were digested with the endoproteinases trypsin, GluC, or
chymotrypsin. N-linked glycans were removed and O-Man
glycopeptides enriched on the lectin Con A. After additional
fractionating, peptides were analyzed by HCD/ETD-MS/MS
(Fig. 1A). This way, we identified 2600 O-mannosylation
sites in 396 unique proteins. Approximately 2300 of these
sites were assigned from ETD peptide spectra (supplemental
Table S2 and supplemental Fig. S1). Further, 880 sites were
assigned from HCD-MS/MS. Taking into account that HCD-
MS/MS spectra suffer from neutral loss of hexose residues
because of the specific mechanisms of fragmentation and
that residual glycan elongation can be observed, these sites
are considered to be ambiguous as long as the modification
sites were not confirmed by ETD-MS/MS. Additional 115 O-
mannosylated proteins were identified based on a hexose
subtraction routine from HCD spectra only, yet glycosylation
sites could not be assigned (detailed under Experimental Pro-
cedures; (21)). All glycopeptides identified with the shotgun
approach are available in supplemental Table S3. For each
protein the number and position of O-Man sites were ex-
tracted from sequence alignments. In the context of the yeast
proteome, these results are available in supplemental Table
S2. Additional information, such as the classification of pro-
teins known or predicted to be translocated into the ER (here-
inafter referred to as the yeast secretome) according to Ast et
al. (38), the number and position of known N-glycosylation
sites determined by Zielinska et al. (39), the subcellular local-
ization and membrane assignment, as well as further informa-
tion compiled from SGD (http://www.yeastgenome.org/) and
the UniProt Knowledgebase (UniProtKB, http://www.uniprot.
org/), is included in supplemental Table S2.
Analysis of the 511 identified O-Man glycoproteins showed
that a total of 293 classified as glycoproteins from the yeast
secretome (Fig. 2A, (38)). Manual inspection revealed a mini-
mum of 10 proteins that we consider part of the secretome
(e.g. members of the cell wall-localized seripauperin family),
and 32 uncharacterized gene products of unknown localiza-
tion and function, reducing the number of nonsecretome O-
Man glycoproteins to a total of 176 (Fig. 2A). These proteins
originate from mitochondria, the cytoplasm or the nucleus,
and are not exposed to the PMT O-mannosylation machinery
in the ER. We propose that the biosynthesis, regulation, and
function are different from the classical O-Man glycoproteins
entering the secretory pathway. Nucleocytoplasmic proteins
that have been identified in a subset of the experiments
presented in this study, are highlighted in supplemental Ta-
bles S2 and S3, and are described separately (22).
Here, we focus only on the 293 secretome proteins con-
taining 2200 O-Man sites (supplemental Table S2), which
are targets of PMT-based O-mannosylation. With regard to
the classification of the yeast secretome by Ast et al. (38), we
found that 26% of the proteins of the yeast secretome contain
O-Man glycans. A considerable fraction of these glycopro-
teins (62%, 182 out of 293) enter the ER in a signal recognition
particle (SRP) -independent manner (Fig. 2A). This fraction of
cellular components is known to be enriched for proteins with
glycosylphosphatidylinositol (GPI) -anchoring sequences, and
indeed, we identified 78% (45 out of 58) of all known or
predicted GPI-anchored proteins to be O-mannosylated (sup-
plemental Table S2). When compared with the yeast pro-
teome, the proportion of cell wall and plasma membrane
proteins is decidedly enriched in the total O-Man glycopro-
teome. In addition, a large fraction of proteins from the vac-
uole and the endomembrane system was found, particularly
proteins from the ER (Fig. 2B, 2C). Cellular compartments
were confirmed performing an automated GO enrichment
analysis using the DAVID database (Fig. 2D, GO_CC). In de-
tail, we assigned O-Man glycans to 68% of all proteins that
are annotated for cell wall localization. Furthermore, 22% of
the ER-localized, 18% of the Golgi-resident, 17% of the vac-
uolar, and 16% of all plasma membrane annotated proteins
are targets of O-mannosylation (Fig. 2C). For the vast majority
of these proteins this post-translational modification is de-
scribed for the very first time. When comparing with the yeast
N-glycoproteome reported by Zielinska et al. (39), we find that
56% (152 out of 272) of the N-glycoproteins also contain
O-Man glycans (supplemental Table S2). Although the overall
ratios between N-glycosylated and O-mannosylated proteins
of the secretory pathway are similar, we found a notably
higher amount of O-Man containing cell wall proteins (Fig.
2C). All glycoproteins and their corresponding classifications
used for these analyses are included in supplemental Table
S2.
We classified the sites of glycosylation into domains of
proteins using the GlycoDomainViewer. This method has pre-
viously been used to better understand the mammalian O-
GalNAc glycoproteome (40) and can be used to compare
general properties of the two glyco-proteomes (see Discus-
sion). The method functions by classifying sites based upon
their position on the protein with respect to conserved folds.
It allows for extraction of glycosylated domains, stem, linker,
and multipass transmembrane loop and tail regions. As shown
in Fig. 3, the major glycodomain classifications places yeast
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O-Man sites outside of protein folds (56% of sites), but not in
linker (4%) or stem (8%) regions. The sites on proteins lacking a
transmembrane domainmake up the largest proportion of these
sites (34%). The next largest glycodomain set is the 23% of the
sites found within domains on proteins. The most common
glycosylated domains are glycoside hydrolase related domains
(IPR013781 and IPR017853, mostly Scw4, Scw10, and Gas1),
the MIR motif found on PMTs (IPR016093) and the thioredoxin
fold as found on protein disulfide isomerase (PDI) family mem-
bers (IPR012336, see below). The data are available online
to explore on the GlycoDomainViewer (http://glycodomain.
glycomics.ku.dk/doi/10.1074/mcp.M115.057505/), where gly-
cosites are viewed in the context of predicted domain struc-
tures of proteins.
Cell Wall Proteins Are Major Targets of O-Mannosylation—
Our shotgun LWAC approach identified 82 unique cell wall
and cell wall-associated proteins for which a total of 1400
(63%) O-Man glycosylation sites were assigned (supple-
mental Table S2). Accordingly, proteins involved in cell wall
organization, protein glycosylation and abiotic stress re-
sponse, especially glycosyltransferase, -hydrolase, and re-
ceptor activities, are significantly enriched in the O-Man gly-
coproteome as can be seen by GO enrichment analyses (Fig.
2D, GO_BP and GO_MF). Some of the cell wall proteins are
4.4
3.9
4.4
7.1
7.6
16.2
17.3
18.0
22.2
68.1
3.9
25.6
7.6
0 20 40 60 80
N.A.
nucleus
endosome
cytosol
mitochrondion
PM
vacuole
Golgi
ER
cell wall
not secretome
secretome
total
Percentage of all compartment 
proteins
N-glycoproteome
O-Man glycoproteome
B
SRP independent
SRP dependent
unpredicted
not secretome
secretome 
O-Man secretome Secretome
potentially secretome
47
16%
182
62.1%
64
21.8% 436
38%
375
32.8%
333
29.1%
176
42
293
O-Man glycoproteomeA
G
O
_B
P
G
O
_M
F
G
O
_C
C
cell wall organisation
protein glycosylation
response to abiotic stress
response to temperature
ERAD
protein translocation
glucan biosynthesis
response to unfolded protein
cellular bud formation
mannosyltransferase activity
O-glycosyl hydrolase activity
receptor activity
mannosidase activity
PDI activity
lipase activity
cell wall
integral to membrane
PM
ER
cellular bud
mating projection
Golgi
organelle membrane
vacuole
Enrichment Score
0 20 40 60
D
0 20 40 60
endosome
Golgi
vacuole
mitochrondion
nucleus
PM
cell wall
cytosol
ER
N.A.
Percentage of all proteins
Proteome
O-Man glycoproteome
C
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molecular function (GO_MF) and cellular compartment (GO_CC) are shown.
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extensively mannosylated, as illustrated by the occurrence of
1122 O-Man sites in only 32 proteins, including among others
structural cell wall proteins (e.g. Hsp150: 76 O-Man sites) as
well as glycosyltransferases and -hydrolases (e.g. Gas1: 52
O-Man sites; Egt2: 48 O-Man sites) (supplemental Table S2).
Using an independent approach targeting cell wall proteins
only, but omitting the LWAC enrichment of glycopeptides, we
validated O-mannosylation for a subset of the cell wall pro-
teins. Thereto, we isolated cell wall fractions from WT yeast
that were enriched for proteins covalently linked to the cell
wall glucan (24). After removal of N-linked glycans by treat-
ment with endoglycosidase H, peptides were prepared using
the endoproteinases LysC, LysN, or ArgN. Then, O-Man gly-
cans of heterogenous length were trimmed with Jack bean
-mannosidase, and the resulting (glyco)peptides analyzed
without further enrichment by HCD/ETD-MS/MS. We identi-
fied a total of 107 O-Man peptides from 24 cell wall proteins
(supplemental Table S4), which largely overlap with the tryptic
glycopeptides found in the total cell lysates from the KTR
mutant (examples are shown in supplemental Fig. S2). In both
types of experiments, a considerable coverage of all potential
generated peptides that are applicable for MS/MS analysis
(i.e. length of 6 to 25 amino acids) was achieved (supplemen-
tal Fig. S2), all in all showing the sensitivity and robustness of
our shotgun LWAC-based method.
O-Man Sites Found Widely on ER and Golgi Resident Pro-
teins—Although it was expected that cell wall proteins are
major carriers of O-Man glycans, it was somewhat surprising
to find that a significant number of O-Man glycosites were
distributed on numerous proteins of the secretory pathway.
Despite few exceptions, O-mannosylation of these proteins
had not been considered yet. ER proteins represent the sec-
ond largest group of proteins in the O-Man glycoproteome
(Fig. 2B–2D). For nine of the 103 ER-annotated proteins, ten
or more O-Man sites could be mapped (supplemental Table
S2). Among those glycoproteins are Sed4 (55 O-Man sites)
and its paralog Sec12 (15 O-Man sites), which are guanine
nucleotide exchange factors required for the initiation of
COPII vesicle formation in ER to Golgi transport (41); Slp1 (21
O-Man sites), an integral ER membrane protein with a sug-
gested role in folding of membrane proteins (42); and the
Hsp70-like chaperone Lhs1 (15 O-Man sites) that acts with
the ER luminal Hsp70 Kar2 during protein import into the ER
(43). For the majority of ER proteins however, less than six
O-Man sites have been mapped (supplemental Table S2). In
addition, especially proteins were found O-mannosylated that
play crucial roles in biological processes and molecular func-
tions associated with the ER, such as protein trafficking (e.g.
Sec12, Sec20), glycosylation (e.g. Pmt1, Ost1, Wbp1), protein
folding and quality control (e.g. Lhs1, Kar2, Pdi1, Rot1) as well
as response to ER stress conditions (e.g. Ire1) (Fig. 2D,
GO_BP, GO_MF). Selected examples are shown in Table I.
In addition to ER proteins, O-Man sites could be assigned
to a total of 38 Golgi-located proteins. Particularly remarkable
is that 13 of these proteins directly function in outer chain
elongation of N-linked glycans. We identified all but two of the
mannosyltransferases involved in this process (Och1; M-PolI:
Mnn1 and Van1; M-PolII: Mnn9, Mnn11 and Hoc1; Mnn2,
Mnn5, Kre2, Ktr4), the GlcNAc-transferase Gnt1, and the pro-
teins involved in the transport of GDP-Man into the Golgi
lumen (Vrg4, Gda1) (supplemental Table S2).
Intriguingly, many of the ER and Golgi located proteins are
orthologous to human proteins. For a total of 3571 yeast
proteins, human orthologs with reasonable sequence similar-
ity can be defined (based on information from SGD). 79 of
these proteins are O-glycosylated in both human and yeast.
Here again, these proteins mainly account for few biological
processes and molecular functions, namely the involvement
in ER quality control and folding, protein sorting and vesicular
transport, and protein disulfide isomerase, phosphatase or
peptidase activities (examples in Table I and supplemental
Fig. S3). When aligning these proteins, we found that in gen-
eral, regions of glycosylation are conserved, and in few cases
even individual sites are shared by O-Man in yeast, and O-
GalNAc and/or O-Man in humans (supplemental Fig. S3). An
example for conserved O-glycosylation is the PDI family. For
the ER luminal PDI – Pdi1 – and three other ER-localized
PDI-like proteins – Eug1, Mpd1, and Eps1 – O-Man glycans
could be specifically assigned. All sites are present in the
domains containing the active site with a CysXXCys motif (Fig.
4A). In Pdi1, one of these sites (Thr452) is placed in a highly-
conserved ProThr-motif (Fig. 4C). An inspection of the recom-
binant yeast Pdi1 crystal structure revealed that this motif is
Within domain
17%
23%
Linker
25%
4%
Stem
12%
8% 
Membrane outside
27%
22%
Outside secreted
14%
34%
Loop
1%
1%
Tail
4%
9%
Legend
Human O-GalNAc
Yeast O-Man
Domain
FIG. 3. Organisation of O-Man sites in protein domains in com-
parison with O-GalNAc. O-Man and O-GalNAc sites were compared
between yeast and human to understand the overall distribution of
glycosylation on proteins. Transmembrane information was retrieved
from UniProt (Oktober, 2015), and domain information retrieved from
Interpro 53.0. Using the “R” package Rgator, sites were classified into
different regions on the protein (glycodomains), and summaries of the
numbers produced.
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directly adjacent to one of the catalytic cysteine residues
(Cys406) (Fig. 4B; (44, 45)). Molecular modeling showed that at
position Thr452 an O-linked mannose can be fitted precisely
into a prominent groove at the protein surface (Fig. 4B, detail
enlargement). O-Man glycans are also present in the con-
served ProThr-motif of the mammalian Pdi1-homolog PDIA3
from human breast cancer cells (21), making Pdi1 a striking
example that emphasizes the relevance of our findings.
O-Mannosylation is Favored in Unstructured Regions and
-Strands—To gain further insight into the molecular features
of target proteins defining PMT-based O-mannosylation, we
analyzed the peptide sequences surrounding the determined
O-Man sites in a sliding window analysis (Fig. 5A). This way,
for every Ser/Thr and every O-Man site in the secretome the
general Ser/Thr-content surrounding the site of interest, the
immediate hydropathy, the FoldIndex(c) as a measure for
structural disorder, and the probability for -helical and
-strand secondary structures (NetSurfP 1.1) were calculated.
These analyses revealed that the majority of O-Man sites are
preferentially placed within regions of a Ser/Thr-content of at
least 20 to 50% (4 to 10 Ser or Thr residues in close
proximity) (Fig. 5D; for individual examples see supplemental
Fig. S2). We not only experimentally confirmed the predictions
made, but also found that glycosylation of Thr is favored over
Ser, and that apart from hydroxyl-amino acids, Ala and Val
residues are preferred in the proximity of the O-Man sites (Fig.
5G, 5H). In contrast, Leu and Asp residues are less favored,
the latter especially at positions 4 to 1. Although we did
not identify evident sequence features suggestive of a glyco-
sylation motif, we found that disordered protein characteris-
tics favor the addition of O-Man glycans (Fig. 5F). Further-
more, O-Man sites are underrepresented in regions with high
-helix probability, but overrepresented in -strand folds (Fig.
5B, 5C).
O-Mannosylation is Impeded by N-Glycosylation—In S.
cerevisiae, numerous proteins contain both, N-linked and O-
Man glycans, and our previous work revealed that these types
of glycosylation can even compete for some acceptor pro-
teins (8, 13). N-glycosylation is initiated at the ER by the
oligosaccharyl transferase (OST) complex, which catalyzes
the transfer of the oligosaccharide GlcNAc2Man9Glc3 from a
lipid-linked donor to Asn residues of the acceptor sequence
Asn-X-Ser/Thr. As shown in Fig. 5H, Asn residues are signif-
icantly under-represented in the direct vicinity of O-Man sites.
Most frequently Asn is absent at the2 position of the O-Man
site, which clearly reflects the N-glycosylation sequon Asn-X-
TABLE I
Selected ER-localized O-Man glycoproteins involved in glycosylation, ER quality control and intracellular trafficking
Function
Identifiers
Essential
Number of sites
Orthologs in human
Locus Name N-glyco (confirmed) O-Man (total)
Glycosylation: N-glyco YJL002C OST1 YES 4 7 GalNAc
Glycosylation: N-glyco YEL002C WBP1 2 6
Glycosylation: N-glyco YMR149W SWP1 6
Glycosylation: O-Man YAL023C PMT2 1 13
Glycosylation: O-Man YDL095W PMT1 3 11
Glycosylation: O-Man YGR199W PMT6 4 3
Glycosylation: O-Man YJR143C PMT4 1
Glycosylation: O-Man YOR321W PMT3 1 1
Quality Control: ERAD YNL008C ASI3 1 1
Quality Control: Folding YOR154W SLP1 3 21
Quality Control: HSP YKL073W LHS1 10 15 GalNAc
Quality Control: HSP YMR200W ROT1 YES 3 13
Quality Control: HSP YJL034W KAR2 YES 8 GalNAc
Quality Control: HSP YOL031C SIL1 7
Quality Control: HSP YMR214W SCJ1 6
Quality Control: HSP YJL073W JEM1 1 1 GalNAc
Quality Control: N-glyco YDR057W YOS9 1 11 GalNAc
Quality Control: N-glyco YAL058W CNE1 4 4
Quality Control: PDI YML130C ERO1 YES 6 11
Quality Control: PDI YDR518W EUG1 2 9 GalNAc/Man
Quality Control: PDI YCL043C PDI1 YES 7 6 GalNAc/Man
Quality Control: PDI YIL005W EPS1 2 5 GalNAc/Man
Quality Control: PDI YOR288C MPD1 2 2 GalNAc/Man
Quality Control: UPR YHR079C IRE1 5
Trafficking: COPI YDR498C SEC20 YES 5
Trafficking: COPII YCR067C SED4 55
Trafficking: COPII YNR026C SEC12 YES 1 15
Trafficking: COPII/p24 YGL200C EMP24 4 GalNAc
Trafficking: COPII YIL039W TED1 3 2
Trafficking: COPII/p24 YML012W ERV25 2 GalNAc
Trafficking: COPII/p24 YDL018C ERP3 2 GalNAc
Trafficking: COPII YAL042W ERV46 1
Trafficking: COPII/p24 YAR002C-A ERP1 1
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Ser/Thr. O-mannosylation of the Ser or Thr in this sequence
was only observed for 25 out of the 836 N-glycosylated se-
quons identified by Zielinska et al. ((39); supplemental Table
S2). Considering the high Ser/Thr content surrounding the
O-Man sites also the Asn residues in the positions 1 to 	3
are likely to represent canonical N-glycosylation motifs.
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The O-Mannose Glycoproteome in Baker’s Yeast
Molecular & Cellular Proteomics 15.4 1331
To further address this aspect, we took advantage of a
cell-free translation/translocation/glycosylation system that
we recently established to study O-mannosylation at the ER
translocon (8). Briefly, reactions were started by mixing a
translation lysate, an mRNA of interest, and yeast WT micro-
somes. Translocation products inside the microsomes were
selected by Proteinase K treatment, resolved by SDS-PAGE
and detected by Western blot. We previously showed that in
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structural disorder. Additionally, values for the probability for -helices and -strand secondary structures were calculated externally using
NetSurfP 1.1. Positions of O-Man modifications were extracted from supplemental Table S3. The corresponding values were plotted in
histograms and bar plots, and the corresponding sequence windows were used for generation of Logo plots. In each case, only proteins and
site information from proteins entering the secretory pathway (according to Ast et al. (38)) were taken into account. B, C, Bar plot summarizing
the results of B, -helix and C, -strand prediction using NetSurfP 1.1. Bars represent the number of O-Man sites (dark gray) in percent that
are located in protein regions with a minimum secondary structure probability as indicated. O-Man sites were compared with the distribution
of all Ser/Thr sites from proteins entering the secretory pathway (light gray). O-Man sites were found underrepresented in regions of high
-helices, but overrepresented in regions of high -strand probability. D–F, Histograms show the results of sliding window calculations of D,
the general Ser/Thr content, E, the hydropathy, and F, the FoldIndex(c) surrounding the O-Man sites. O-Man sites (black) were compared with
the distribution of all Ser/Thr positions in the secretome (gray). O-Man sites were found to be overrepresented in regions of 30–50% Ser/Thr
content. In addition to that, O-Man sites are situated in hydrophilic and intrinsically disordered protein regions. G, One-sided Logo plot of
analyzed sequence windows (using WebLogo 3.4). Size of the characters indicates the occurrence of amino acids within the sequence
windows surrounding the O-Man site. Amino acids are colored according to their hydrophobicity: hydrophilic amino acids are blue, neutral
amino acids are green, and hydrophobic amino acids are black. H, Two-sided Logo-plot of analyzed sequence windows (using Two Sample
Logo). Sequence windows of O-Man sites were compared against the sequence windows of all Ser/Thr positions in the secretome. A threshold
for enrichment and depletion of p  0.01 was used. Amino acids are colored according to their chemical properties: polar amino acids are
depicted in green, neutral amino acids are purple, basic amino acids are blue, acidic amino acids are red, and hydrophobic amino acids are
black.
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this system, the protein Ccw5 is efficiently decorated with
O-Man glycans (8, 13). Based on this protein, we designed a
model substrate containing a short stretch of Ser/Thr residues
(TSSQATSS, supplemental Fig. S4), which are O-mannosy-
lated in yeast microsomes, as indicated by the fuzzy appear-
ance of the translocation product shown in Fig. 6A (compare
lane 1 with lane 2 and 3). O-mannosylation of the translocated
protein was further confirmed by Con A lectin affinity pull
down and LC-MS/MS (supplemental Fig. S4). A sequon se-
quence centered in or N-terminal of the Ser/Thr-stretch was
predominantly N-glycosylated (Fig. 6B; Endo H treatment,
compare in panel a or b, lanes 3 and 4 with lane 2), leading to
a significant reduction of O-mannosylation of the neighboring
Ser/Thr residues (Fig. 6A, 6B; compare lane A2 with lane B2 in
panel a and b). In agreement with our glycoproteome data,
increasing the distance between the sequon and the Ser/Thr-
stretch partly restored O-mannosylation (Fig. 6B; panel c).
Placing the N-glycan acceptor site C-terminally to the hy-
droxyl amino acids, we observed the same result although the
effect was less pronounced (Fig. 6B; panels d and e). The
microsomal data are in good agreement with our proteome-
wide findings that O-mannosylation is less frequent at and in
the close proximity of N-glycan acceptor sites.
DISCUSSION
This study presents a comprehensive map of the yeast
O-Man glycoproteome illustrating that O-Man glycosylation
affects a wide range of proteins from all major subcellular
compartments. Here, we only focused on the O-Man glyco-
proteome of the secretome. We found that at least 26% of the
proteins that enter the secretory pathway (a total of 293
proteins) bear O-Man glycans. For the vast majority of these
glycoproteins O-mannosylation has not been shown before,
including more than 30 previously uncharacterized proteins of
the cell wall and the secretory pathway (supplemental Table
S2).
Cell Wall O-Man Glycoproteins—The yeast cell wall is an
essential structure that is made of -glucan (50%), manno-
proteins (50%), and chitin (2%) (46). Mannoproteins were
found to be N-glycosylated, O-mannosylated, or both. Con-
ditional pmt deletion mutants show various cell wall-related
phenotypes (2, 47), and inhibition of O-mannosylation results
in activation of cell wall integrity signaling pathways (48),
emphasizing the crucial role of this modification for the bio-
synthesis and the maintenance of a functional cell wall. Ac-
cordingly, in the O-Man glycoproteome proteins involved in
cell wall organization and stress response are clearly overrep-
resented (Fig. 2D). In particular, we assigned O-Man glycans
to 78% of all known or predicted GPI-anchored proteins,
which represent more than half of all cell wall annotated
proteins (supplemental Table S2). In relation to the yeast
N-glycoproteome described by Zielinska et al. (39), we found
a similar proportion of ER and Golgi glycoproteins, but iden-
tified a considerably higher number of cell wall proteins
(Fig. 2C).
We identified about 1400 O-mannosylation sites compared
with 225 confirmed N-glycosylation sites (according to (39);
supplemental Table S2). In baker’s yeast, about 12% of the
protein-linked mannose residues can be released by -elim-
ination (49). Considering a mean number of 3 and 120
mannose residues per O- and N-linked glycan chain, respec-
tively, one can estimate that in average cell wall proteins
contain around five to six times more O- than N-linked gly-
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FIG. 6. Context dependent O-mannosylation of a model accep-
tor substrate in in vitro translation/translocation/glycosylation
assays. A, B, O- and N-linked glycosylation was monitored in vitro
using a cell free translation/translocation/glycosylation assay de-
scribed by Loibl et al. (8). A, Translated proteins and translocation
products in the presence of yeast microsomes (yM) of the FLAG-
tagged Ccw5-based model substrate TSTQATSS (schematically rep-
resented in supplemental Fig. S4) and B, the indicated derivatives
thereof are shown. Details are outlined under Experimental Proce-
dures. Translocation products were confirmed in the presence of
Proteinase K (ProtK) and the detergent Triton X-100 (TX-100). Pro-
teins of purified microsomes were treated with Endo H to remove
N-linked glycans. Proteins were separated by SDS-PAGE and ana-
lyzed by Western blot using anti-FLAG antibodies.
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cans. Our data match closely with this prediction, which un-
derscores the quality and validity of the established O-Man
glycoproteome. Still, the extent of O-mannosylation in cell
wall proteins is almost certainly underestimated, considering
that in some of the Ser/Thr-rich regions of cell wall proteins
protease cleavage sites are rare (supplemental Fig. S2, e.g.
Aga1, Cwp1), and that because of technical constraints de-
tection of highly O-glycosylated peptides is limited.
ER and Golgi O-Man Glycoproteins—We found that 22%
and 18% of all proteins curated for ER and Golgi localization,
respectively, are represented in the O-Man glycoproteome.
O-mannosylation has previously been described for a few
heavily glycosylated ER proteins, such as Sed4 (41) and
Sec12 (50), which were confirmed to be significantly O-man-
nosylated in our study (supplemental Table S2). For the ma-
jority of the moderately O-mannosylated proteins, this modi-
fication has been overlooked so far.
Many proteins involved in N-glycosylation, such as the OST
subunits Ost1, Wbp1, and Swp1; the trimming glycosidases
Cwh41, Mnl1, Mnl2, and Mns1; as well as most of the Golgi
mannosyltransferases involved in N-glycan processing were
found to be O-mannosylated. Recent transcriptome analyses
of pmt mutants identified a compensatory response between
O- and N-glycosylation, which particularly affects the forma-
tion of high mannose outer chains (48). In view of this finding,
O-mannosylation of many of the biosynthetic enzymes of
N-linked glycans is especially intriguing and might even reflect
a regulatory role. Further, O-Man glycans could also be as-
signed to members of the p24 complex involved in the export
of GPI-anchored proteins from the ER and the GPI-glycan
remodelase Ted1. This finding is specifically significant in the
light of the previously reported physical interaction with these
proteins and yeast PMTs (51). In addition, numerous proteins
with chaperone function such as Lhs1, Kar2, or Rot1; the
unfolded protein response receptor Ire1; and proteins in-
volved in the antero- and retrograde ER–Golgi trafficking such
as Sec12 and Sec20, were identified. In Candida albicans,
O-mannosylation positively affects the stability of the essen-
tial v-SNARE protein Sec20 that functions in retrograde trans-
port from the Golgi to the ER (52), showing that O-Man
glycans of ER proteins can directly affect protein perform-
ance. Furthermore, remarkable are the observed O-Man gly-
cans in the ER-luminal PDIs and PDI-like proteins – Pdi1,
Eug1, Mpd1, and Eps1, as well as the thiol oxidase Ero1 (Fig.
4). Oxidative protein folding in the ER is an essential function
of eukaryotic cells. The yeast Ero1 oxidase transfers oxidizing
equivalents to PDI, which transfers them to newly synthesized
polypeptides leading to the formation or rearrangement of
protein disulfide bonds (reviewed in (53)). Both, Ero1 and Pdi1
have been previously identified as interactors of PMTs (51).
Ero1 contains O-Man glycans mainly in the essential C-termi-
nal region that tethers the protein to ER membrane compo-
nents (supplemental Fig. S3; (54)). In all yeast PDIs the O-Man
glycans are in the proximity of the catalytic CysXXCys motifs,
where also N-linked glycans are present ((53), Fig. 4A). It
remains a challenging task to unravel the functions of these
glycans for ER and Golgi homeostasis in the future.
Sequence Motifs for O-Mannosylation?—In yeast, the PMT
family is highly redundant (Pmt1–6) and falls into three sub-
families (PMT1, PMT2, PMT4) (reviewed in (11)). Pmt1/Pmt2
and Pmt4 act on distinct proteins, but despite the fact that
Pmt4 preferentially modifies membrane-anchored proteins,
parameters that define substrate recognition have not been
identified yet (18, 37). The O-Man glycoproteome revealed
various but indistinct characteristics of O-Man sites, which
might be attributed, at least in part, to the different substrate
and/or glycosylation site specificities of the yeast PMT family
members. As anticipated, the majority of O-Man sites are
situated in protein regions of about 20–50% Ser/Thr-content,
which are hydrophilic in nature and often present intrinsically
disordered domains (Figs. 3, 5). We further observed that
O-mannosylation is favored in regions with higher probability
to form -strands (Fig. 5). In accordance with our data, a
recent study investigating the conformational properties of
different O-linked sugars using force field molecular dynamics
simulation showed the conformational stabilization of -
strands and polyproline type II conformations over -helices
via intramolecular hydrogen bonds and bridging water mole-
cules (55).
We found that like in humans, O-mannosylation of Thr is
favored over Ser (Fig. 5; (21, 56)). In yeast, apart from hy-
droxyl-amino acids, Ala and Val residues are preferred in the
proximity of the O-Man sites, whereas Asp and Leu residues
are less favored (Fig. 5). Our findings are in good agreement
with previous in vitro studies addressing PMT acceptor sites,
using synthetic penta-peptides (19, 47). In mammals, Pro
residues support the nearby addition of O-GalNAc residues
(57). Although previous studies on synthetic penta-peptides
as well as the here identified ProThr-motif on PDI suggest
similar for yeast O-mannosylation ((47); Fig. 4C), a significant
overall enrichment of Pro in the proximity of O-Man glycosites
was not observed (Fig. 5). Having established a shotgun strat-
egy to probe the O-Man glycoproteome we can now move
forward with studying PMT isoform specificities similar to
what has recently been developed for O-GalNAc using quan-
titative differential O-glycoproteomics (58).
Interplay with N-Glycosylation—Our study revealed that at
the sequon sequence Asn-X-Ser/Thr, N- is favored over O-
glycosylation and that in the immediate vicinity of N-glycosy-
lation acceptor sites O-mannosylation is also less prevalent
(Figs. 5 and 6). A hallmark of N-glycosylation is the require-
ment of a Ser or Thr residue at the	2 position of the acceptor
site, because the corresponding hydroxyl group is important
for the positioning of the peptide substrate to the active site of
OST (59). Hence, O-mannosylation of the acceptor sequon
would render N-glycosylation virtually impossible. In agree-
ment, we only found few reported N-glycosylation sequons to
be O-mannosylated. Also in vitro N-glycosylation of the model
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substrate TSSQATSS clearly predominated (Fig. 6). However,
when this sequence is placed C-terminal of an extended
Ser/Thr-rich region, as naturally occurring in the cell wall
protein Ccw5, O-mannosylation is favored (8, 13). Overall,
these data show that the mutual influence between the two
glycosylation types at N-glycan acceptor sites depends very
much on the surrounding protein context. The interplay of O-
and N-glycosylation is almost certainly a considerable factor
determining micro- (i.e. local structure/conformation of gly-
cans) and macro- (i.e. glycan site usage) heterogeneity of
glycoproteins in yeast and mammals, and will be an interest-
ing subject toward deciphering the undoubtedly immense role
of protein glycosylation.
Yeast versus Mammalian O-glycosylation—In fungi, O-
mannosylation is the only type of O-glycosylation, whereas in
higher eukaryotes O-mannosylation is so far mainly restricted
to specific cell surface and extracellular matrix proteins such
as -dystroglycan, KIAA1549, members of the cadherin and
plexin superfamilies and lecticans (21, 60). Although cell sur-
face proteins vary substantially between yeast and mammals,
basic characteristics of O-mannosylation are highly similar
((21); see above). Besides cell surface decoration and hence
cell wall organization or cell adhesion, respectively, our study
now provides clear indications for further conserved, but so
far unrecognized functions of O-mannosylation, as in the case
of PDI (Fig. 4; see above).
In contrast to yeast, however, mucin-type O-GalNAc glyco-
sylation became the most common covalent modification of
Ser and Thr residues in mammals. Analysis of orthologs pro-
teins from yeast and human revealed a set of common sub-
strates, and glycodomain classification and sequence align-
ments showed a partial overlap of glycosites or domains.
Yeast O-Man and human O-GalNAc glycosylation share the
same prevalence for acceptor sites outside of protein folding
domains. However,O-mannosylation is less prevalent in linker
or stem regions (Fig. 3), but more frequently found in the C-
and N-terminal regions (data not shown). Positions of glyco-
sylation suggest direct conserved biological functions for se-
lected proteins. As an example, the human aspartyl proteases
cathepsin D (CTSD) and yeast proteinase A (Pep4) are puta-
tive orthologs (supplemental Fig. S3). Their alignment shows a
high degree of sequence conservation in their catalytic do-
mains. For both enzymes, there is a glycosylation site in the
activation peptide, which is the linker between the propeptide
and the catalytic domain. At the carboxy-terminal of this
peptide, both orthologous proteins are cleaved to produce the
mature protein, and both sets of glycosylation sites exhibit
proximity to cleavage sites suggesting protection from pro-
peptide removal (61). Similar mechanisms were recently de-
scribed for the aspartic endopeptidase Yps1, where O-man-
nosylation regulates its shedding activity of GPI-anchored
proteins (62).
In summary, our study provides a deep insight into the
O-Man glycoproteome of yeast and shows that O-Man gly-
cosylation is found widely not only on cell wall proteins but
also ER and Golgi proteins. O-mannosylation of some or-
thologous proteins is highly conserved between yeast and
mammals. However, in most mammalian proteins O-Man gly-
cans appear to have been replaced by O-GalNAc glycosyla-
tion, which may conserve the general function of the protein-
linked carbohydrate, but in addition, may introduce new
beneficial physicochemical properties to the protein (55).
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